CLIVUNEL INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CLIVUNEL INC, and when can generic versions of CLIVUNEL INC drugs launch?
CLIVUNEL INC has one approved drug.
There are two US patents protecting CLIVUNEL INC drugs.
There are twenty-four patent family members on CLIVUNEL INC drugs in eighteen countries and fifteen supplementary protection certificates in fourteen countries.
Drugs and US Patents for CLIVUNEL INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clivunel Inc | SCENESSE | afamelanotide | IMPLANT;SUBCUTANEOUS | 210797-001 | Oct 8, 2019 | RX | Yes | Yes | 8,334,265 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Clivunel Inc | SCENESSE | afamelanotide | IMPLANT;SUBCUTANEOUS | 210797-001 | Oct 8, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Clivunel Inc | SCENESSE | afamelanotide | IMPLANT;SUBCUTANEOUS | 210797-001 | Oct 8, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Clivunel Inc | SCENESSE | afamelanotide | IMPLANT;SUBCUTANEOUS | 210797-001 | Oct 8, 2019 | RX | Yes | Yes | 10,076,555 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CLIVUNEL INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hungary | E035074 | ⤷ Try a Trial |
Slovenia | 2056855 | ⤷ Try a Trial |
Japan | 2008508324 | ⤷ Try a Trial |
European Patent Office | 2865422 | ⤷ Try a Trial |
Denmark | 2865422 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CLIVUNEL INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2865422 | 132018000000241 | Italy | ⤷ Try a Trial | PRODUCT NAME: AFAMELANOTIDE(SCENESSE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/969, 20141229 |
2865422 | SPC/GB18/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: AFAMELANOTIDE; REGISTERED: UK EU/1/14/969 (NI) 20141222; UK PLGB 30619/0002 20141222 |
2865422 | C201830012 | Spain | ⤷ Try a Trial | PRODUCT NAME: AFAMELANOTIDA; NATIONAL AUTHORISATION NUMBER: EU/1/14/969; DATE OF AUTHORISATION: 20141222; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/969; DATE OF FIRST AUTHORISATION IN EEA: 20141222 |
2865422 | 405 8-2018 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: AFAMELANOTID; REGISTRATION NO/DATE: EU/1/14/969 20141229 |
2865422 | CR 2018 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: AFAMELANOTID; REG. NO/DATE: EU/1/14/969 20141229 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.